
PB 102 of 2025
National Health (Weighted average disclosed price – October 2025 reduction day) Amendment Determination 2025
I, REBECCA RICHARDSON, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated: 27 August 2025
Rebecca Richardson
Assistant Secretary
PBS Listing, Pricing and Policy Branch
Technology Assessment and Access Division
Department of Health, Disability and Ageing
This instrument commences on the day after it is registered.
This instrument is made under subsection 99ADB(4) of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1 Amendments
National Health (Weighted average disclosed price – October 2025 reduction day) Determination 2025 (PB 71 of 2025).
omit:
3 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Abrilada | 455.15 |
4 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Amgevita | 455.15 |
5 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Hadlima | 455.15 |
6 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Hyrimoz | 455.15 |
7 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Abrilada | 455.15 |
8 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Amgevita | 455.15 |
9 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Hadlima | 455.15 |
10 | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Hyrimoz | 455.15 |
omit:
21 | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
22 | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
23 | Atomoxetine | Capsule 100 mg (as hydrochloride) | Oral | APO-Atomoxetine | 27.76 |
24 | Atomoxetine | Capsule 100 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 27.76 |
25 | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
26 | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
27 | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
28 | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
29 | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
30 | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
31 | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
32 | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
33 | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | APO-Atomoxetine | 27.76 |
34 | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 27.76 |
omit:
149 | Estradiol | Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses | Transdermal | Estrogel | 18.06 |
omit:
159 | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Atozet | 6.22 |
160 | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetast | 6.22 |
161 | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetimibe/Atorvastatin GH 10/10 | 6.22 |
162 | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Atozet | 6.68 |
163 | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetast | 6.68 |
164 | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetimibe/Atorvastatin GH 10/20 | 6.68 |
omit:
243 | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP | 5.1 |
244 | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | HYDROMORPHONE JUNO-HP | 5.1 |
245 | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Hydromorphone-hameln-HP | 5.1 |
246 | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE HP 10 mg/1 mL | 5.1 |
247 | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid | 3.83 |
248 | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | HYDROMORPHONE JUNO | 3.83 |
249 | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Hydromorphone-hameln | 3.83 |
250 | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE 2 mg/1 mL | 3.83 |
omit:
277 | Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | 214.24 |
omit:
316 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | APO-Latanoprost/Timolol 0.05/5 | 5.74 |
317 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalacom | 5.74 |
318 | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalamol 50/5 | 5.74 |
omit:
371 | Morphine | Injection containing morphine sulfate pentahydrate 10 mg in 1 mL | Injection | MORPHINE SULFATE 10 mg/1 mL MEDSURGE | 4.04 |
omit:
381 | Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | Palonosetron Dr.Reddy's | 2.93 |
382 | Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | PALONOSETRON Medsurge | 2.93 |
after:
440 | Risperidone | Tablet 4 mg | Oral | Rixadone | 12.95 |
insert:
440A | Rivaroxaban | Capsule 15 mg | Oral | Relaban | 26.99 |
440B | Rivaroxaban | Capsule 20 mg | Oral | Relaban | 26.66 |
omit:
415 | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Risperdal | 65.97 |
416 | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Risperidone Lupin | 65.97 |
417 | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Rixadone | 65.97 |
omit:
465 | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Tenofovir APOTEX | 55.79 |
466 | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | TENOFOVIR ARX | 55.79 |
467 | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Tenofovir Sandoz | 55.79 |
468 | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Viread | 55.79 |
omit:
471 | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Herzuma | 104 |
472 | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Ogivri | 104 |
473 | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Trazimera | 104 |
omit:
474 | Trastuzumab | Powder for I.V. infusion 440 mg with diluent | Injection | Herzuma | 269.17 |
omit:
475 | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Sandoz | 186.84 |
476 | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Viatris | 186.84 |
omit:
486 | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Aclasta | 43.94 |
487 | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Osteovan | 43.94 |
488 | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Zoledasta | 43.94 |
489 | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Zoledronate-RDY 5 | 43.94 |
after:
34 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled pen | Injection | Hadlima | 455.15 |
35 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled pen | Injection | Humira | 455.15 |
36 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled pen | Injection | Hyrimoz | 455.15 |
37 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled pen | Injection | Yuflyma | 455.15 |
insert:
37A | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Abrilada | 455.15 |
37B | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Amgevita | 455.15 |
37C | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Hadlima | 455.15 |
37D | Adalimumab | Injection 40 mg in 0.8 mL pre-filled pen | Injection | Hyrimoz | 455.15 |
after:
38 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled syringe | Injection | Hadlima | 455.15 |
39 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled syringe | Injection | Humira | 455.15 |
40 | Adalimumab | Injection 40 mg in 0.4 mL pre-filled syringe | Injection | Yuflyma | 455.15 |
insert:
40A | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Abrilada | 455.15 |
40B | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Amgevita | 455.15 |
40C | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Hadlima | 455.15 |
40D | Adalimumab | Injection 40 mg in 0.8 mL pre-filled syringe | Injection | Hyrimoz | 455.15 |
after:
313 | Atenolol | Tablet 50 mg | Oral | Tensig | 4 |
insert:
313A | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
313B | Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
313C | Atomoxetine | Capsule 100 mg (as hydrochloride) | Oral | APO-Atomoxetine | 27.76 |
313D | Atomoxetine | Capsule 100 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 27.76 |
313E | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
313F | Atomoxetine | Capsule 18 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
313G | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
313H | Atomoxetine | Capsule 25 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
313I | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
313J | Atomoxetine | Capsule 40 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
313K | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Atomoxetine | 21.35 |
313L | Atomoxetine | Capsule 60 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 21.35 |
313M | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | APO-Atomoxetine | 27.76 |
313N | Atomoxetine | Capsule 80 mg (as hydrochloride) | Oral | Atomoxetine Sandoz | 27.76 |
after:
352 | Azithromycin | Tablet 500 mg (as dihydrate) | Oral | Zithromax | 4 |
insert:
352A | Azithromycin | Tablet 500 mg (as dihydrate) (S19A) | Oral | Azithromycin Tablets, USP 500 mg (Precision Dose, USA) | 455.15 |
after:
1029 | Estradiol | Transdermal gel 500 micrograms in 0.5 g sachet, 28 | Transdermal | Sandrena | 7.92 |
insert:
1029A | Estradiol | Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses | Transdermal | Estrogel | 18.06 |
after:
1089 | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Rosuzet Composite Pack | 10.75 |
insert:
1089A | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Atozet | 6.22 |
1089B | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetast | 6.22 |
1089C | Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetimibe/Atorvastatin GH 10/10 | 6.22 |
1089D | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Atozet | 6.68 |
1089E | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetast | 6.68 |
1089F | Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetimibe/Atorvastatin GH 10/20 | 6.68 |
after:
1373 | Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | 15.6 |
insert:
1373A | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP | 5.1 |
1373B | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | HYDROMORPHONE JUNO-HP | 5.1 |
1373C | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Hydromorphone-hameln-HP | 5.1 |
1373D | Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE HP 10 mg/1 mL | 5.1 |
1373E | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid | 3.83 |
1373F | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | HYDROMORPHONE JUNO | 3.83 |
1373G | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Hydromorphone-hameln | 3.83 |
1373H | Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE 2 mg/1 mL | 3.83 |
after:
1413 | Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | 158.01 |
insert:
1413A | Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | 214.24 |
after:
1571 | Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye | Xalatan | 4 |
insert:
1571A | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | APO-Latanoprost/Timolol 0.05/5 | 5.74 |
1571B | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalacom | 5.74 |
1571C | Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye | Xalamol 50/5 | 5.74 |
after:
1897 | Methylphenidate | Capsule containing methylphenidate hydrochloride 60 mg (modified release) | Oral | Rubifen LA | 45.23 |
insert:
1897A | Methylphenidate | Capsule containing methylphenidate hydrochloride 10 mg (modified release) (s19A) | Oral | Methylphenidate Orifarm 10 mg (Sweden) | 136.62 |
1897B | Methylphenidate | Capsule containing methylphenidate hydrochloride 20 mg (modified release) (s19A) | Oral | Methylphenidate Orifarm 20 mg (Sweden) | 146.04 |
1897C | Methylphenidate | Capsule containing methylphenidate hydrochloride 30 mg (modified release) (s19A) | Oral | Methylphenidate Orifarm 30 mg (Sweden) | 155.47 |
1897D | Methylphenidate | Capsule containing methylphenidate hydrochloride 60 mg (modified release) (s19A) | Oral | Methylphenidate Orifarm 60 mg (Denmark) | 200.22 |
after:
1911 | Methylphenidate | Tablet containing methylphenidate hydrochloride 54 mg (extended release) | Oral | METHYLPHENIDATE-TEVA XR | 45.45 |
insert:
1911A | Methylphenidate | Tablet containing methylphenidate hydrochloride 18 mg (extended release) (S19A) | Oral | Concerta (Switzerland) | 141.34 |
1911B | Methylphenidate | Tablet containing methylphenidate hydrochloride 18 mg (extended release) Concerta (Switzerland) (S19A) | Oral | Concerta (Switzerland) | 188.54 |
1911C | Methylphenidate | Tablet containing methylphenidate hydrochloride 27 mg (extended release) (S19A) | Oral | Concerta (Switzerland) | 150.4 |
1911D | Methylphenidate | Tablet containing methylphenidate hydrochloride 36 mg (extended release) (S19A) | Oral | Concerta (Switzerland) | 168.22 |
1911E | Methylphenidate | Tablet containing methylphenidate hydrochloride 36 mg (extended release) Concerta (Switzerland) (S19A) | Oral | Concerta (Switzerland) | 248.54 |
1911F | Methylphenidate | Tablet containing methylphenidate hydrochloride 54 mg (extended release) (S19A) | Oral | Concerta (Switzerland) | 190.44 |
1911G | Methylphenidate | Tablet containing methylphenidate hydrochloride 54 mg (extended release) Concerta (Switzerland) (S19A) | Oral | Concerta (Switzerland) | 287.5 |
after:
2037 | Morphine | Injection containing morphine hydrochloride trihydrate 50 mg in 5 mL | Injection | Morphine Juno | 11.28 |
insert:
2037A | Morphine | Injection containing morphine sulfate pentahydrate 10 mg in 1 mL | Injection | MORPHINE SULFATE 10 mg/1 mL MEDSURGE | 4.04 |
after:
2103 | Naltrexone | Tablet containing naltrexone hydrochloride 50 mg | Oral | Naltrexone GH | 72.38 |
insert:
2103A | Naproxen | Oral suspension 125 mg per 5 mL, 474 mL (S19A) | Oral | Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada) | 132.93 |
after:
2317 | Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral | Pharmacor Olmesartan HCTZ 40/25 | 5.14 |
insert:
2317A | Omalizumab | Injection 150 mg in 1 mL single dose pre-filled pen | Injection | Xolair | 208.55 |
2317B | Omalizumab | Injection 300 mg in 2 mL single dose pre-filled pen | Injection | Xolair | 417.09 |
2317C | Omalizumab | Injection 75 mg in 0.5 mL single dose pre-filled pen | Injection | Xolair | 104.28 |
after:
2400 | Paclitaxel | Solution concentrate for I.V. infusion 300 mg in 50 ml | Injection | Paclitaxel Ebewe | 34.63 |
insert:
2400A | Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | Palonosetron Dr.Reddy's | 2.93 |
2400B | Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection | PALONOSETRON Medsurge | 2.93 |
after:
2624 | Prazosin | Capsule 1 mg (as hydrochloride) (S19A) | Oral | Prazosin Hydrochloride Capsules, USP 1 mg (Novitium Pharma, USA) | 39.66 |
insert:
2624A | Prazosin | Capsule 2 mg (as hydrochloride) (S19A) | Oral | Prazosin Hydrochloride Capsules, USP 2 mg (Novitium Pharma, USA) | 61.91 |
after:
2862 | Risperidone | Tablet 1 mg | Oral | Rixadone | 4 |
insert:
2862A | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Risperdal | 65.97 |
2862B | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Risperidone Lupin | 65.97 |
2862C | Risperidone | Oral solution 1 mg per mL, 100 mL | Oral | Rixadone | 65.97 |
after:
3345 | Temozolomide | Capsule 5 mg | Oral | Temozolomide Juno | 4 |
insert:
3200A | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Tenofovir APOTEX | 55.79 |
3200B | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | TENOFOVIR ARX | 55.79 |
3200C | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Tenofovir Sandoz | 55.79 |
3200C | Tenofovir | Tablet containing tenofovir disoproxil fumarate 300 mg | Oral | Viread | 55.79 |
after:
3329 | Tranexamic acid | Tablet 500 mg | Oral | Tranexamic Acid Lupin | 22.7 |
insert:
3329A | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Herzuma | 104 |
3329B | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Kanjinti | 104 |
3329C | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Ogivri | 104 |
3329D | Trastuzumab | Powder for I.V. infusion 150 mg | Injection | Trazimera | 104 |
3329E | Trastuzumab | Powder for I.V. infusion 440 mg with diluent | Injection | Herzuma | 269.17 |
after:
3365 | Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral | Zelitrex | 4 |
insert:
3365A | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Sandoz | 186.84 |
3365B | Valganciclovir | Tablet 450 mg (as hydrochloride) | Oral | Valganciclovir Viatris | 186.84 |
after:
3454 | Ziprasidone | Capsule 80 mg (as hydrochloride) | Oral | ZIPROX | 98.81 |
insert:
3454A | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Aclasta | 43.94 |
3454B | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Osteovan | 43.94 |
3454C | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Zoledasta | 43.94 |
3454D | Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection | Zoledronate-RDY 5 | 43.94 |